Sign In
15 Mar 2012 16:09
ο»Ώ
15 March 2012
Β
Ark Therapeutics Group plc
Β
Directors' Share Dealing
Β
Β
Ark Therapeutics Group plc (LSE: AKT) ("the "Company") has received notification that on 14 March 2012:
Β
1. Dr David Bloxham, Non-Executive Director, purchased 273,972 ordinary shares of 1p each in the Company at a price of 3.65p per share.
2. Iain Ross, Executive Chairman, through his Self Invested Pension Plan ("SIPP"), purchased 822,000 ordinary shares of 1p each in the Company at a price of 3.65p per share.
3. Charles Spicer, Non-Executive Director, through his SIPP, purchased 551,395 ordinary shares of 1p each in the Company at a price of 3.60p per share.
4. Martyn Williams, Chief Executive Officer, through his SIPP, purchased 274,000 ordinary shares of 1p each in the Company at a price of 3.63p per share.
Β
For further information please contact:
Β
Ark Therapeutics Group plc | +44 (0)20 7388 7722 |
Dr Edward Bliss, Company Secretary |
Β
Β
Follow the stocks
